Page last updated: 2024-08-22

methylprednisolone hemisuccinate and Chronic Disease

methylprednisolone hemisuccinate has been researched along with Chronic Disease in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19902 (40.00)18.7374
1990's1 (20.00)18.2507
2000's0 (0.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brunet, BA; Stewart, P; Sugg, RM1
Ajduk, J; Gregurić, T; Kalogjera, L; Kelava, I; Košec, A; Ries, M1
Camara, DS; Jusko, WJ; Kong, AN; Ludwig, EA1
Ruderman, MI; Turkewitz, LJ1
Honda, H; Jyoichi, T; Miyahara, T; Noda, Y; Shmojo, S1

Other Studies

5 other study(ies) available for methylprednisolone hemisuccinate and Chronic Disease

ArticleYear
Hypereosinophilic syndrome presenting acutely with neurologic signs.
    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2018, Volume: 120, Issue:5

    Topics: Aged; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Arthralgia; Chronic Disease; Churg-Strauss Syndrome; Cough; Diagnosis, Differential; Eosinophils; Humans; Hypereosinophilic Syndrome; Hypokinesia; Magnetic Resonance Imaging; Male; Methylprednisolone Hemisuccinate; Nasal Polyps; Prednisone; Rhinitis, Allergic; Thrombophilia; Treatment Outcome

2018
Recovery From Sudden Sensorineural Hearing Loss May Be Linked to Chronic Stress Levels and Steroid Treatment Resistance.
    American journal of audiology, 2019, Jun-10, Volume: 28, Issue:2

    Topics: Adult; Audiometry, Pure-Tone; Chronic Disease; Cluster Analysis; Cohort Studies; Female; Glucocorticoids; Hearing Loss, Sensorineural; Hearing Loss, Sudden; Humans; Longitudinal Studies; Male; Methylprednisolone Hemisuccinate; Middle Aged; Prognosis; Recovery of Function; Retrospective Studies; Stress, Psychological; Treatment Outcome

2019
Pharmacokinetics of methylprednisolone hemisuccinate and methylprednisolone in chronic liver disease.
    Journal of clinical pharmacology, 1993, Volume: 33, Issue:9

    Topics: Adult; Chronic Disease; Half-Life; Humans; Hydrocortisone; Hypertension, Portal; Liver Cirrhosis, Alcoholic; Male; Methylprednisolone; Methylprednisolone Hemisuccinate; Middle Aged

1993
Current therapy of demyelinating neuropathies.
    The Mount Sinai journal of medicine, New York, 1985, Volume: 52, Issue:6

    Topics: Adrenocorticotropic Hormone; Adult; Charcot-Marie-Tooth Disease; Child; Chronic Disease; Combined Modality Therapy; Demyelinating Diseases; Humans; Immunosuppressive Agents; Methylprednisolone Hemisuccinate; Neoplasms; Nervous System Diseases; Paraproteinemias; Plasmapheresis; Polyradiculoneuropathy; Prednisolone; Prednisone; Respiration, Artificial

1985
[Plasmapheresis-pulse therapy in chronic stage of Guillain-Barré syndrome--controlled study].
    Rinsho shinkeigaku = Clinical neurology, 1987, Volume: 27, Issue:4

    Topics: Activities of Daily Living; Adult; Chronic Disease; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Male; Methylprednisolone; Methylprednisolone Hemisuccinate; Middle Aged; Plasmapheresis; Polyradiculoneuropathy

1987